Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
VHH-His tag NanoAb™ Targeting Human EGFR, clone 1019 (FITC)
VHH-His tag NanoAb™ Targeting Human EPCAM, clone 6025
VHH-His tag NanoAb™ Targeting Human EPCAM, clone 6025 (FITC)
VHH-His tag NanoAb™ Targeting Human FX, clone 1112
VHH-His tag NanoAb™ Targeting Human IFNG, clone 4136
VHH-His tag NanoAb™ Targeting Human IFNG, clone 4136 (FITC)
VHH-His tag NanoAb™ Targeting Human IL6, clone 4139
VHH-His tag NanoAb™ Targeting Human IL6, clone 4139 (FITC)
VHH-His tag NanoAb™ Targeting Human MSR1, clone E035
VHH-His tag NanoAb™ Targeting Human MSR1, clone E035 (FITC)
VHH-His tag NanoAb™ Targeting Human NGFR, clone 1046
VHH-His tag NanoAb™ Targeting Human P-selectin, clone 1079